aluates Reports

$ 0.0

Automative

Global Flu Prevention Market Research Report 2024

Published Date: November 2024

Report Code: QYRE-Auto-2T18685

BUY CHAPTERS

Global Flu Prevention Market Research Report 2024

Code: QYRE-Auto-2T18685

Report

November 2024

Pages:94

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

GSK

CSL Limited

CSL Ltd

Sanofi

Sanofi S A

Viatris

Astrazeneca plc

Hualan Bio

Changchun Institute of Biological

Sinovac

BCHT

Jiangsu GDK

KM Biologics

Flu Prevention Market Size

The global Flu Prevention market was valued at US$ 8530 million in 2023 and is anticipated to reach US$ 12380 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.

Flu Prevention Market

Flu prevention encompasses a range of measures aimed at reducing the risk of influenza infection. Key methods include annual vaccination, which is the most effective way to prevent flu, along with practices such as frequent handwashing, avoiding close contact with infected individuals, and maintaining good hygiene. For those at high risk, like young children, elderly adults, and individuals with chronic health conditions, flu prevention is crucial to reduce the chance of severe illness and complications.

Global key players of Vaccine for Influenza include Sanofi, CSL and GSK, etc. The top five players hold a share about 75%. North America is the largest market, has a share about 50%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Flu Prevention, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flu Prevention.

The Flu Prevention market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Flu Prevention market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Flu Prevention manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Flu Prevention Market Report

Report Metric	Details
Report Name	Flu Prevention Market
Accounted market size in 2023	US$ 8530 million
Forecasted market size in 2030	US$ 12380 million
CAGR	5.5%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Trivalent Influenza Vaccine Quadrivalent Influenza Vaccine
Segment by Application	6 Months to 3 Years > 3 Years
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, BCHT, Jiangsu GDK, KM Biologics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Flu Prevention manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Flu Prevention in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Flu Prevention Market growing?

Ans: The Flu Prevention Market witnessing a CAGR of 5.5% during the forecast period 2024-2030.

What is the Flu Prevention Market size in 2030?

Ans: The Flu Prevention Market size in 2030 will be US$ 12380 million.

What is the market share of major companies in Flu Prevention Market?

Ans: The top five players hold a share about 75%.

What is the Flu Prevention Market share by region?

Ans: North America is the largest market, has a share about 50%.

Who are the main players in the Flu Prevention Market report?

Ans: The main players in the Flu Prevention Market are Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, BCHT, Jiangsu GDK, KM Biologics

What are the Application segmentation covered in the Flu Prevention Market report?

Ans: The Applications covered in the Flu Prevention Market report are 6 Months to 3 Years, > 3 Years

What are the Type segmentation covered in the Flu Prevention Market report?

Ans: The Types covered in the Flu Prevention Market report are Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine

Recommended Reports

Influenza Vaccines

Vaccine Delivery

Viral and Anti-Infectives

1 Flu Prevention Market Overview

1.1 Product Definition

1.2 Flu Prevention by Type

1.2.1 Global Flu Prevention Market Value Comparison by Type (2024-2030)

1.2.2 Trivalent Influenza Vaccine

1.2.3 Quadrivalent Influenza Vaccine

1.3 Flu Prevention by Application

1.3.1 Global Flu Prevention Market Value by Application (2024-2030)

1.3.2 6 Months to 3 Years

1.3.3 > 3 Years

1.4 Global Flu Prevention Market Size Estimates and Forecasts

1.4.1 Global Flu Prevention Revenue 2019-2030

1.4.2 Global Flu Prevention Sales 2019-2030

1.4.3 Global Flu Prevention Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Flu Prevention Market Competition by Manufacturers

2.1 Global Flu Prevention Sales Market Share by Manufacturers (2019-2024)

2.2 Global Flu Prevention Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Flu Prevention Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Flu Prevention, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Flu Prevention, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Flu Prevention, Product Type & Application

2.7 Global Key Manufacturers of Flu Prevention, Date of Enter into This Industry

2.8 Global Flu Prevention Market Competitive Situation and Trends

2.8.1 Global Flu Prevention Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Flu Prevention Players Market Share by Revenue

2.8.3 Global Flu Prevention Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Flu Prevention Market Scenario by Region

3.1 Global Flu Prevention Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Flu Prevention Sales by Region: 2019-2030

3.2.1 Global Flu Prevention Sales by Region: 2019-2024

3.2.2 Global Flu Prevention Sales by Region: 2025-2030

3.3 Global Flu Prevention Revenue by Region: 2019-2030

3.3.1 Global Flu Prevention Revenue by Region: 2019-2024

3.3.2 Global Flu Prevention Revenue by Region: 2025-2030

3.4 North America Flu Prevention Market Facts & Figures by Country

3.4.1 North America Flu Prevention Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Flu Prevention Sales by Country (2019-2030)

3.4.3 North America Flu Prevention Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Flu Prevention Market Facts & Figures by Country

3.5.1 Europe Flu Prevention Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Flu Prevention Sales by Country (2019-2030)

3.5.3 Europe Flu Prevention Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Flu Prevention Market Facts & Figures by Region

3.6.1 Asia Pacific Flu Prevention Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Flu Prevention Sales by Region (2019-2030)

3.6.3 Asia Pacific Flu Prevention Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Flu Prevention Market Facts & Figures by Country

3.7.1 Latin America Flu Prevention Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Flu Prevention Sales by Country (2019-2030)

3.7.3 Latin America Flu Prevention Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Flu Prevention Market Facts & Figures by Country

3.8.1 Middle East and Africa Flu Prevention Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Flu Prevention Sales by Country (2019-2030)

3.8.3 Middle East and Africa Flu Prevention Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Flu Prevention Sales by Type (2019-2030)

4.1.1 Global Flu Prevention Sales by Type (2019-2024)

4.1.2 Global Flu Prevention Sales by Type (2025-2030)

4.1.3 Global Flu Prevention Sales Market Share by Type (2019-2030)

4.2 Global Flu Prevention Revenue by Type (2019-2030)

4.2.1 Global Flu Prevention Revenue by Type (2019-2024)

4.2.2 Global Flu Prevention Revenue by Type (2025-2030)

4.2.3 Global Flu Prevention Revenue Market Share by Type (2019-2030)

4.3 Global Flu Prevention Price by Type (2019-2030)

5 Segment by Application

5.1 Global Flu Prevention Sales by Application (2019-2030)

5.1.1 Global Flu Prevention Sales by Application (2019-2024)

5.1.2 Global Flu Prevention Sales by Application (2025-2030)

5.1.3 Global Flu Prevention Sales Market Share by Application (2019-2030)

5.2 Global Flu Prevention Revenue by Application (2019-2030)

5.2.1 Global Flu Prevention Revenue by Application (2019-2024)

5.2.2 Global Flu Prevention Revenue by Application (2025-2030)

5.2.3 Global Flu Prevention Revenue Market Share by Application (2019-2030)

5.3 Global Flu Prevention Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Sanofi

6.1.1 Sanofi Company Information

6.1.2 Sanofi Description and Business Overview

6.1.3 Sanofi Flu Prevention Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Sanofi Flu Prevention Product Portfolio

6.1.5 Sanofi Recent Developments/Updates

6.2 CSL

6.2.1 CSL Company Information

6.2.2 CSL Description and Business Overview

6.2.3 CSL Flu Prevention Sales, Revenue and Gross Margin (2019-2024)

6.2.4 CSL Flu Prevention Product Portfolio

6.2.5 CSL Recent Developments/Updates

6.3 GSK

6.3.1 GSK Company Information

6.3.2 GSK Description and Business Overview

6.3.3 GSK Flu Prevention Sales, Revenue and Gross Margin (2019-2024)

6.3.4 GSK Flu Prevention Product Portfolio

6.3.5 GSK Recent Developments/Updates

6.4 Viatris

6.4.1 Viatris Company Information

6.4.2 Viatris Description and Business Overview

6.4.3 Viatris Flu Prevention Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Viatris Flu Prevention Product Portfolio

6.4.5 Viatris Recent Developments/Updates

6.5 AstraZeneca

6.5.1 AstraZeneca Company Information

6.5.2 AstraZeneca Description and Business Overview

6.5.3 AstraZeneca Flu Prevention Sales, Revenue and Gross Margin (2019-2024)

6.5.4 AstraZeneca Flu Prevention Product Portfolio

6.5.5 AstraZeneca Recent Developments/Updates

6.6 Hualan Bio

6.6.1 Hualan Bio Company Information

6.6.2 Hualan Bio Description and Business Overview

6.6.3 Hualan Bio Flu Prevention Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Hualan Bio Flu Prevention Product Portfolio

6.6.5 Hualan Bio Recent Developments/Updates

6.7 Changchun Institute of Biological

6.7.1 Changchun Institute of Biological Company Information

6.7.2 Changchun Institute of Biological Description and Business Overview

6.7.3 Changchun Institute of Biological Flu Prevention Sales, Revenue and Gross Margin (2019-2024)

6.7.4 Changchun Institute of Biological Flu Prevention Product Portfolio

6.7.5 Changchun Institute of Biological Recent Developments/Updates

6.8 Sinovac

6.8.1 Sinovac Company Information

6.8.2 Sinovac Description and Business Overview

6.8.3 Sinovac Flu Prevention Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Sinovac Flu Prevention Product Portfolio

6.8.5 Sinovac Recent Developments/Updates

6.9 BCHT

6.9.1 BCHT Company Information

6.9.2 BCHT Description and Business Overview

6.9.3 BCHT Flu Prevention Sales, Revenue and Gross Margin (2019-2024)

6.9.4 BCHT Flu Prevention Product Portfolio

6.9.5 BCHT Recent Developments/Updates

6.10 Jiangsu GDK

6.10.1 Jiangsu GDK Company Information

6.10.2 Jiangsu GDK Description and Business Overview

6.10.3 Jiangsu GDK Flu Prevention Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Jiangsu GDK Flu Prevention Product Portfolio

6.10.5 Jiangsu GDK Recent Developments/Updates

6.11 KM Biologics

6.11.1 KM Biologics Company Information

6.11.2 KM Biologics Description and Business Overview

6.11.3 KM Biologics Flu Prevention Sales, Revenue and Gross Margin (2019-2024)

6.11.4 KM Biologics Flu Prevention Product Portfolio

6.11.5 KM Biologics Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Flu Prevention Industry Chain Analysis

7.2 Flu Prevention Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Flu Prevention Production Mode & Process

7.4 Flu Prevention Sales and Marketing

7.4.1 Flu Prevention Sales Channels

7.4.2 Flu Prevention Distributors

7.5 Flu Prevention Customers

8 Flu Prevention Market Dynamics

8.1 Flu Prevention Industry Trends

8.2 Flu Prevention Market Drivers

8.3 Flu Prevention Market Challenges

8.4 Flu Prevention Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

GSK

CSL Limited

CSL Ltd

Sanofi

Sanofi S A

Viatris

Astrazeneca plc

Hualan Bio

Changchun Institute of Biological

Sinovac

BCHT

Jiangsu GDK

KM Biologics

List of Tables

Table 1. Global Flu Prevention Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Flu Prevention Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Flu Prevention Market Competitive Situation by Manufacturers in 2023

Table 4. Global Flu Prevention Sales (M Doses) of Key Manufacturers (2019-2024)

Table 5. Global Flu Prevention Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Flu Prevention Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Flu Prevention Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Flu Prevention Average Price (USD/Doses) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Flu Prevention, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Flu Prevention, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Flu Prevention, Product Type & Application

Table 12. Global Key Manufacturers of Flu Prevention, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Flu Prevention by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flu Prevention as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Flu Prevention Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Flu Prevention Sales by Region (2019-2024) & (M Doses)

Table 18. Global Flu Prevention Sales Market Share by Region (2019-2024)

Table 19. Global Flu Prevention Sales by Region (2025-2030) & (M Doses)

Table 20. Global Flu Prevention Sales Market Share by Region (2025-2030)

Table 21. Global Flu Prevention Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Flu Prevention Revenue Market Share by Region (2019-2024)

Table 23. Global Flu Prevention Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Flu Prevention Revenue Market Share by Region (2025-2030)

Table 25. North America Flu Prevention Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Flu Prevention Sales by Country (2019-2024) & (M Doses)

Table 27. North America Flu Prevention Sales by Country (2025-2030) & (M Doses)

Table 28. North America Flu Prevention Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Flu Prevention Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Flu Prevention Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Flu Prevention Sales by Country (2019-2024) & (M Doses)

Table 32. Europe Flu Prevention Sales by Country (2025-2030) & (M Doses)

Table 33. Europe Flu Prevention Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Flu Prevention Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Flu Prevention Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Flu Prevention Sales by Region (2019-2024) & (M Doses)

Table 37. Asia Pacific Flu Prevention Sales by Region (2025-2030) & (M Doses)

Table 38. Asia Pacific Flu Prevention Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Flu Prevention Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Flu Prevention Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Flu Prevention Sales by Country (2019-2024) & (M Doses)

Table 42. Latin America Flu Prevention Sales by Country (2025-2030) & (M Doses)

Table 43. Latin America Flu Prevention Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Flu Prevention Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Flu Prevention Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Flu Prevention Sales by Country (2019-2024) & (M Doses)

Table 47. Middle East and Africa Flu Prevention Sales by Country (2025-2030) & (M Doses)

Table 48. Middle East and Africa Flu Prevention Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Flu Prevention Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Flu Prevention Sales (M Doses) by Type (2019-2024)

Table 51. Global Flu Prevention Sales (M Doses) by Type (2025-2030)

Table 52. Global Flu Prevention Sales Market Share by Type (2019-2024)

Table 53. Global Flu Prevention Sales Market Share by Type (2025-2030)

Table 54. Global Flu Prevention Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Flu Prevention Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Flu Prevention Revenue Market Share by Type (2019-2024)

Table 57. Global Flu Prevention Revenue Market Share by Type (2025-2030)

Table 58. Global Flu Prevention Price (USD/Doses) by Type (2019-2024)

Table 59. Global Flu Prevention Price (USD/Doses) by Type (2025-2030)

Table 60. Global Flu Prevention Sales (M Doses) by Application (2019-2024)

Table 61. Global Flu Prevention Sales (M Doses) by Application (2025-2030)

Table 62. Global Flu Prevention Sales Market Share by Application (2019-2024)

Table 63. Global Flu Prevention Sales Market Share by Application (2025-2030)

Table 64. Global Flu Prevention Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Flu Prevention Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Flu Prevention Revenue Market Share by Application (2019-2024)

Table 67. Global Flu Prevention Revenue Market Share by Application (2025-2030)

Table 68. Global Flu Prevention Price (USD/Doses) by Application (2019-2024)

Table 69. Global Flu Prevention Price (USD/Doses) by Application (2025-2030)

Table 70. Sanofi Company Information

Table 71. Sanofi Description and Business Overview

Table 72. Sanofi Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 73. Sanofi Flu Prevention Product

Table 74. Sanofi Recent Developments/Updates

Table 75. CSL Company Information

Table 76. CSL Description and Business Overview

Table 77. CSL Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 78. CSL Flu Prevention Product

Table 79. CSL Recent Developments/Updates

Table 80. GSK Company Information

Table 81. GSK Description and Business Overview

Table 82. GSK Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 83. GSK Flu Prevention Product

Table 84. GSK Recent Developments/Updates

Table 85. Viatris Company Information

Table 86. Viatris Description and Business Overview

Table 87. Viatris Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 88. Viatris Flu Prevention Product

Table 89. Viatris Recent Developments/Updates

Table 90. AstraZeneca Company Information

Table 91. AstraZeneca Description and Business Overview

Table 92. AstraZeneca Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 93. AstraZeneca Flu Prevention Product

Table 94. AstraZeneca Recent Developments/Updates

Table 95. Hualan Bio Company Information

Table 96. Hualan Bio Description and Business Overview

Table 97. Hualan Bio Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 98. Hualan Bio Flu Prevention Product

Table 99. Hualan Bio Recent Developments/Updates

Table 100. Changchun Institute of Biological Company Information

Table 101. Changchun Institute of Biological Description and Business Overview

Table 102. Changchun Institute of Biological Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 103. Changchun Institute of Biological Flu Prevention Product

Table 104. Changchun Institute of Biological Recent Developments/Updates

Table 105. Sinovac Company Information

Table 106. Sinovac Description and Business Overview

Table 107. Sinovac Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 108. Sinovac Flu Prevention Product

Table 109. Sinovac Recent Developments/Updates

Table 110. BCHT Company Information

Table 111. BCHT Description and Business Overview

Table 112. BCHT Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 113. BCHT Flu Prevention Product

Table 114. BCHT Recent Developments/Updates

Table 115. Jiangsu GDK Company Information

Table 116. Jiangsu GDK Description and Business Overview

Table 117. Jiangsu GDK Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 118. Jiangsu GDK Flu Prevention Product

Table 119. Jiangsu GDK Recent Developments/Updates

Table 120. KM Biologics Company Information

Table 121. KM Biologics Description and Business Overview

Table 122. KM Biologics Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 123. KM Biologics Flu Prevention Product

Table 124. KM Biologics Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Flu Prevention Distributors List

Table 128. Flu Prevention Customers List

Table 129. Flu Prevention Market Trends

Table 130. Flu Prevention Market Drivers

Table 131. Flu Prevention Market Challenges

Table 132. Flu Prevention Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Product Picture of Flu Prevention

Figure 2. Global Flu Prevention Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Flu Prevention Market Share by Type: 2023 & 2030

Figure 4. Trivalent Influenza Vaccine Product Picture

Figure 5. Quadrivalent Influenza Vaccine Product Picture

Figure 6. Global Flu Prevention Market Value by Application (2024-2030) & (US$ Million)

Figure 7. Global Flu Prevention Market Share by Application: 2023 & 2030

Figure 8. 6 Months to 3 Years

Figure 9. > 3 Years

Figure 10. Global Flu Prevention Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 11. Global Flu Prevention Market Size (2019-2030) & (US$ Million)

Figure 12. Global Flu Prevention Sales (2019-2030) & (M Doses)

Figure 13. Global Flu Prevention Average Price (USD/Doses) & (2019-2030)

Figure 14. Flu Prevention Report Years Considered

Figure 15. Flu Prevention Sales Share by Manufacturers in 2023

Figure 16. Global Flu Prevention Revenue Share by Manufacturers in 2023

Figure 17. Global 5 and 10 Largest Flu Prevention Players: Market Share by Revenue in Flu Prevention in 2023

Figure 18. Flu Prevention Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 19. Global Flu Prevention Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 20. North America Flu Prevention Sales Market Share by Country (2019-2030)

Figure 21. North America Flu Prevention Revenue Market Share by Country (2019-2030)

Figure 22. U.S. Flu Prevention Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 23. Canada Flu Prevention Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Europe Flu Prevention Sales Market Share by Country (2019-2030)

Figure 25. Europe Flu Prevention Revenue Market Share by Country (2019-2030)

Figure 26. Germany Flu Prevention Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. France Flu Prevention Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. U.K. Flu Prevention Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Italy Flu Prevention Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Russia Flu Prevention Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Flu Prevention Sales Market Share by Region (2019-2030)

Figure 32. Asia Pacific Flu Prevention Revenue Market Share by Region (2019-2030)

Figure 33. China Flu Prevention Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Japan Flu Prevention Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. South Korea Flu Prevention Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. India Flu Prevention Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Australia Flu Prevention Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. China Taiwan Flu Prevention Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Indonesia Flu Prevention Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Thailand Flu Prevention Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Malaysia Flu Prevention Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Latin America Flu Prevention Sales Market Share by Country (2019-2030)

Figure 43. Mexico Flu Prevention Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Brazil Flu Prevention Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Argentina Flu Prevention Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Middle East and Africa Flu Prevention Sales Market Share by Country (2019-2030)

Figure 47. Middle East and Africa Flu Prevention Revenue Market Share by Country (2019-2030)

Figure 48. Turkey Flu Prevention Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Flu Prevention Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. UAE Flu Prevention Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Global Sales Market Share of Flu Prevention by Type (2019-2030)

Figure 52. Global Revenue Market Share of Flu Prevention by Type (2019-2030)

Figure 53. Global Flu Prevention Price (USD/Doses) by Type (2019-2030)

Figure 54. Global Sales Market Share of Flu Prevention by Application (2019-2030)

Figure 55. Global Revenue Market Share of Flu Prevention by Application (2019-2030)

Figure 56. Global Flu Prevention Price (USD/Doses) by Application (2019-2030)

Figure 57. Flu Prevention Value Chain

Figure 58. Flu Prevention Production Process

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Flu Vaccination Market Research Report 2025

Global Flu Vaccine Market Insights Forecast to 2030

Global Human Injection Flu Vaccine Market Research Report 2025

Global Injection Influenza Vaccine Market Research Report 2025

Global Flu RNA Vaccines Market Research Report 2025

Global Injection Flu Shot Market Research Report 2025

Global Influenza Subunit Vaccine Market Research Report 2024

Children Influenza Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti Influenza Virus Chinese Medicine Market Research Report 2024

Flu Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti H1N1 Liquid Mask Market Research Report 2025

Global Egg Based Flu Vaccines Market Research Report 2024

Influenza Virus Vaccine H1N1 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Adult Preventable Vaccines Market Research Report 2024

Global Egg free Flu Vaccine Market Research Report 2024

Global Poultry Vaccines Market Research Report 2025

Global Paediatric Influenza Treatment Market Research Report 2024

Global Adjuvanted Influenza Vaccine Market Research Report 2024

Global Pediatric Influenza Treatment Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions